Avid Bioservices, Inc. (CDMO) Social Stream
AVID BIOSERVICES INC (CDMO) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering AVID BIOSERVICES INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-01 | 4 | $29 | $27 | $28.333 | $6.29 | 350.45% |
| 2021-10-14 | 4 | $29 | $27 | $28.25 | $6.29 | 349.13% |
| 2021-12-08 | 4 | $35 | $29 | $32 | $6.29 | 408.74% |
| 2022-01-03 | 4 | $35 | $31 | $32.666 | $6.29 | 419.33% |
| 2022-04-01 | 3 | $35 | $28 | $31.666 | $6.29 | 403.43% |
| 2022-10-03 | 3 | $35 | $22 | $28.333 | $6.29 | 350.45% |
| 2022-11-01 | 3 | $35 | $22 | $27.666 | $6.29 | 339.84% |
| 2022-12-07 | 3 | $26 | $20 | $23.666 | $6.29 | 276.25% |
| 2023-01-03 | 3 | $25 | $20 | $22.333 | $6.29 | 255.06% |
| 2023-04-03 | 3 | $25 | $20 | $21.75 | $6.29 | 245.79% |
| 2023-05-01 | 3 | $25 | $20 | $22.25 | $6.29 | 253.74% |
| 2023-06-22 | 3 | $25 | $17 | $21.5 | $6.29 | 241.81% |
| 2023-09-07 | 3 | $25 | $17 | $20.5 | $6.29 | 225.91% |
| 2023-09-08 | 3 | $25 | $15 | $20 | $6.29 | 217.97% |
| 2023-10-02 | 4 | $25 | $15 | $20 | $6.29 | 217.97% |
| 2023-11-01 | 4 | $25 | $15 | $19.25 | $6.29 | 206.04% |
| 2023-12-08 | 5 | $17 | $14 | $15.5 | $6.29 | 146.42% |
The Trend in the Analyst Price Target
CDMO's average price target has moved down $6.25 over the prior 38 weeks.
Over the past 38 weeks, CDMO's average upside potential has been 105.89%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-03 | 3 | 25 | 20 | 21.75 | 18.750 | 16% |
| 2023-06-22 | 3 | 25 | 17 | 21.50 | 13.740 | 56.48% |
| 2023-06-22 | 3 | 25 | 17 | 20.50 | 13.740 | 49.2% |
| 2023-09-08 | 3 | 25 | 15 | 20.00 | 10.825 | 84.76% |
| 2023-11-01 | 4 | 25 | 15 | 19.25 | 5.850 | 229.06% |
CDMO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.6 | 3 | 1 | 1 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
CDMO's average broker recommendation rating worsened by 0.27 over the prior 31 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CDMO as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, AVID BIOSERVICES INC's upside potential (average analyst target price relative to current price) is greater than 1793.01% of them.
- AVID BIOSERVICES INC's number of analysts covering the stock is greater than 215.3% of all US stocks.
- In terms of how AVID BIOSERVICES INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -273.24% of that group.
- To contextualize these metrics, consider that out of stocks in the small market cap category, AVID BIOSERVICES INC's average analyst price target is higher than 1226.96% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to AVID BIOSERVICES INC are TXMD, PLRX, and CALT.
View All Top Stocks by Price Target
Make investment decisions regarding CDMO using the data that counts. Try POWR Ratings for free.